Scholtz & Company’s OrthoPediatrics KIDS Stock Holding History

Scholtz & Company’s Portfolio KIDS Stock Details KIDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-71,838	Closed	-$3.3M	–	75
2020 Q3	$3.3M	Buy	71,838 +13,555	+23%	+$629K	1.44%	27
2020 Q2	$2.55M	Buy	58,283 +26,875	+86%	+$1.21M	1.27%	29
2020 Q1	$1.25M	Sell	31,408 -12,062	-28%	-$541K	0.95%	32
2019 Q4	$2.04M	Buy	43,470 +2,340	+6%	+$90.6K	1.19%	32
2019 Q3	$1.45M	Buy	41,130 +34,455	+516%	+$1.19M	0.97%	36
2019 Q2	$260K	Buy	6,675 +985	+17%	+$39.7K	0.17%	54
2019 Q1	$252K	Buy	+5,690	New	+$216K	0.17%	47
2018 Q4	–	Sell	-35,540	Closed	-$1.3M	–	52
2018 Q3	$1.3M	Buy	+35,540	New	+$1.09M	0.82%	35

Other funds holding KIDS

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SPPAM

Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Scholtz & Company's KIDS Position: Q4 2020 in Review

Scholtz & Company sold out of OrthoPediatrics (KIDS) in Q4 2020, closing a stake of 71,838 shares — an estimated $3.3M sold.

Scholtz & Company first reported a position in KIDS in Q3 2018 and held it in 8 quarters. The position peaked at $3.3M in Q3 2020. 133 funds tracked by Wall St. Rank hold KIDS as of Q4 2020.

Scholtz & Company reported no remaining OrthoPediatrics position as of Q4 2020 after selling out during the quarter.
Scholtz & Company sold 71,838 OrthoPediatrics shares in Q4 2020, an estimated $3.3M.
Scholtz & Company first reported a position in OrthoPediatrics in Q3 2018 and held it in 8 quarters.
Scholtz & Company's OrthoPediatrics position peaked at $3.3M in Q3 2020.
133 funds tracked by Wall St. Rank held OrthoPediatrics as of Q4 2020.

Based on Scholtz & Company's 13F filing for Q4 2020, filed 12 Feb 2021.